Associations of intimate partner violence and maternal comorbidities: a cross-sectional analysis of the Pregnancy Risk Assessment Monitoring System.

Autor:	Hartwell M; Department of Psychiatry and Behavioral Sciences, Oklahoma State University Center for Health Sciences, Tulsa, OK, USA.; Oklahoma State University College of Osteopathic Medicine, Tahlequah, OK, USA., Keener A; College of Osteopathic Medicine, Oklahoma State University Center for Health Sciences, Tulsa, OK, USA., Robling K; Oklahoma State University College of Osteopathic Medicine, Tahlequah, OK, USA., Enmeier M; Oklahoma State University College of Osteopathic Medicine, Tahlequah, OK, USA., Sajjadi NB; College of Osteopathic Medicine, Oklahoma State University Center for Health Sciences, Tulsa, OK, USA., Greiner B; Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX, USA., Price J; Department of Obstetrics and Gynecology, University of Oklahoma School of Community Medicine, Tulsa, OK, USA.
Jazyk:	angličtina
Zdroj:	Journal of osteopathic medicine [J Osteopath Med] 2023 Mar 22; Vol. 123 (8), pp. 405-410. Date of Electronic Publication: 2023 Mar 22 (Print Publication: 2023).
DOI:	10.1515/jom-2023-0018
Abstrakt:	Context: Intimate partner violence (IPV) occurs when an intimate partner inflicts physical, sexual, and/or emotional assault with coercive control and is a traumatic experience with repercussions that can be exacerbated when a woman is pregnant. While screening for IPV during pregnancy is recommended to occur regardless of risk, less than 50% of pregnant women are screened. Objectives: Identifying clinical factors commonly associated with IPV during pregnancy may improve screening rates, thus our primary objective was to examine associations between IPV and maternal comorbidities. Methods: We conducted a cross-sectional analysis of the Pregnancy Risk Assessment Monitoring System (PRAMS) Phase 8 spanning 2016 through 2019. Bivariate and multivariable logistic regression was utilized to calculate adjusted odds ratios (AORs) to determine associations between IPV and diabetes, anxiety, hypertension, depression, asthma, polycystic ovary syndrome (PCOS), and thyroid disease. Results: More than 40% of women experiencing IPV reported a history of depression or anxiety. The occurrence of IPV was higher among women with depression (AOR 3.48, CI 3.14-3.85), anxiety (AOR 2.98, CI 2.64-3.37), hypertension (AOR 1.21, CI 1.02-1.44), and asthma (AOR 1.37; CI 1.17-1.59) than women without those respective conditions, but not among diagnoses of diabetes, PCOS, or thyroid disorders. Conclusions: Our findings show that pregnant individuals reporting having experienced IPV were more likely to report having certain comorbidities compared to those who did not report experiencing IPV. Given the low rates of screening, knowing clinically relevant associations may increase screening sensitivity among clinicians and, in turn, increase the likelihood that individuals experiencing IPV receive supportive care. (© 2023 the author(s), published by De Gruyter, Berlin/Boston.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu